We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Plaque Excision System Designed for Small Vessels

By HospiMedica International staff writers
Posted on 21 Jun 2011
A system treats calcified and noncalcified lesion morphologies in small vessels, broadening minimally invasive treatment options for Peripheral Arterial Disease (PAD). More...


The TurboHawk Plaque Excision System boasts an innovative design that allows for greater cutting efficiency, providing physicians with more consistent performance and patients with a faster recovery period and shorter hospital visits. The core of the system is the Super Cutter Blade, comprised of four angled cutter blades with a unique design that addresses all plaque morphologies, including moderately to severe calcified lesions. The Smooth Cutter Blade, on the other hand, is designed for the treatment of mild-to-moderately calcified lesions with the added convenience of on-the-wire cleaning. Micro Efficient Compression (MEC) technology, based on tiny laser drilled holes in the nosecone, regulate the release of cleansing fluid to the lesion, allowing greater tissue collection.

Among the other advancements of the system are the turbo catheter jog, which consistently cuts across a wider vessel range, reducing the need for multiple catheters, and potentially reducing procedure costs. The versatile dual-jog configuration is effective in vessels of 3.5 mm - 7.0 mm in diameter, controlling maximum apposition force in smaller vessel diameters and improving cutter apposition force in increasing vessel diameters. A new four-layered, counter-wound drive shaft delivers more power to the cutting blade, with more efficient energy transfer to improve cutting performance and affording smoother passes with less effort to cut through the lesion. The TurboHawk Plaque Excision System is a product of Covidien (North Haven, CT, USA), and has been approved by the US Food and Drug Administration (FDA).

"The TurboHawk Plaque Excision System for small vessels will provide physicians and healthcare professionals with a minimally invasive solution that can improve patient outcomes in the treatment of PAD," said Joe Woody, president of vascular therapies at Covidien. "The new system further exemplifies Covidien's commitment to PAD and improving patients overall quality of life."

Related Links:

Covidien



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.